Get In Touch

Footnotes

1. Gordon PB. The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening. Curr Oncol. 2022;29(5):3595-3636. Published 2022 May 17. doi:10.3390/curroncol29050291. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140155/
2. FDA PMA P110006 summary of safety and effectiveness. https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110006B.pdf
4. Henschke CI, et al., A 20-year follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Radiology 2023; DOI: 10.1148/radiol.231988.
5. Selove R, Kilbourne B, Fadden MK, et al. Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization. Women’s Health Issues. 2016;26(6):642-647. doi:10.1016/j.whi.2016.09.003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116399
6. Chang SB, et al. SS2-06. Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment. Presented at: San Antonio Breast Cancer Symposium, 2020. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1186409
7. Based on a simulated user evaluation of OncoFlow at a UK University hospital in a test environment with 15 external users familiar with cancer patient medical records (7 oncologist, 5 nurses, 2 practitioners, 1 MDT coordinator). Each participant completed a series of tasks using both their existing EMR system and OncoCare. Mouse clicks and time to perform each task were recorded. User experience feedback was collected with a survey questionnaire. The study was facilitated by a third-party consulting agency and sponsored by GE HealthCare. The results are not prescriptive and could vary depending on user, electronic patient medical records software used, and circumstances.
8. Global Oncology Trends 2019, IQVIA Institute, ©2019 IQVIA, May 2019. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-oncology-trends-2019
9. MEDraysintell 2021; Marketed Radiopharmaceuticals Report & Directory – Edition 2021.
10. Schenkel C, Levit LA, Kirkwood MK, et al. The state of professional wellbeing and satisfaction among US oncologists. Presented at ASCO Quality Care Symposium 2023. October 27-28, 2023. Boston, Massachusetts. Abstract. https://meetings.asco.org/abstracts-presentations/228098

* Revolution™ is a trademark of GE HealthCare, One-Stop Clinic™ is a trademark of GE HealthCare
** **Optellum Virtual Nodule Clinic is a third-party application distributed by GE HealthCare. Optellum Virtual Nodule Clinic software has been trained using multiple databases of CT scans and eventual diagnoses from healthcare systems in the UK, US, and Europe.